Polaris Group (6550.TW)

TWD 38.0

(-5.59%)

Net Debt Summary of Polaris Group

  • Polaris Group's latest annual net debt in 2023 was -2.41 Billion TWD , up 64.66% from previous year.
  • Polaris Group's latest quarterly net debt in 2024 Q2 was -572 Million TWD , up 66.53% from previous quarter.
  • Polaris Group reported annual net debt of -6.84 Billion TWD in 2022, down -25.77% from previous year.
  • Polaris Group reported annual net debt of -5.44 Billion TWD in 2021, down -3239.24% from previous year.
  • Polaris Group reported quarterly net debt of -1.7 Billion TWD for 2024 Q1, up 29.35% from previous quarter.
  • Polaris Group reported quarterly net debt of -2.41 Billion TWD for 2023 Q4, up 54.81% from previous quarter.

Annual Net Debt Chart of Polaris Group (2023 - 2016)

Historical Annual Net Debt of Polaris Group (2023 - 2016)

Year Net Debt Net Debt Growth
2023 -2.41 Billion TWD 64.66%
2022 -6.84 Billion TWD -25.77%
2021 -5.44 Billion TWD -3239.24%
2020 173.37 Million TWD 107.43%
2019 -2.33 Billion TWD -464.94%
2018 639.37 Million TWD 108.6%
2017 306.5 Million TWD -73.58%
2016 1.16 Billion TWD 0.0%

Peer Net Debt Comparison of Polaris Group

Name Net Debt Net Debt Difference
Apex Biotechnology Corp. -201.21 Million TWD -1102.175%
Sinphar Pharmaceutical Co.,Ltd. 870.53 Million TWD 377.871%
Panion & Bf Biotech Inc. 193.2 Million TWD 1351.996%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 939.54 Million TWD 357.461%
GenMont Biotech Incorporation 2.71 Million TWD 89294.58%
Abnova (Taiwan) Corporation -415.8 Million TWD -481.747%
Adimmune Corporation 685.12 Million TWD 453.066%
Tanvex BioPharma, Inc. 1.35 Billion TWD 279.046%
Energenesis Biomedical CO.,LTD. -246.6 Million TWD -880.892%
UnicoCell Biomed Co., Ltd. 54.43 Million TWD 4544.161%
PELL Bio-Med Technology Co. Ltd. 4.88 Million TWD 49658.636%